Alere Company Profile (NYSE:ALR)

About Alere

Alere logoAlere Inc. is a provider of health information through diagnostic tests. The Company's segments include professional diagnostics, consumer diagnostics, and corporate and other. The professional diagnostics segment includes an array of diagnostic test products and other in vitro diagnostic tests marketed to medical professionals and laboratories for detection of diseases and conditions within its areas of focus. The consumer diagnostics segment consists primarily of manufacturing operations related to its role as the exclusive manufacturer of products for SPD Swiss Precision Diagnostics (SPD), its joint venture with The Procter & Gamble Company (P&G). The Company's professional diagnostic solutions allow patients and their healthcare providers to work together to manage patients' conditions over the continuum of care, from the hospital to home. The Company offers lines of drugs-of-abuse tests, reagent systems and laboratory testing options.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Laboratories & Research
  • Sub-Industry: Health Care Supplies
  • Exchange: NYSE
  • Symbol: ALR
  • CUSIP: 01449J10
Key Metrics:
  • Previous Close: $40.06
  • 50 Day Moving Average: $39.34
  • 200 Day Moving Average: $40.39
  • 52-Week Range: $31.47 - $54.13
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 17.57
  • P/E Growth: 2.08
  • Market Cap: $3.51B
  • Outstanding Shares: 87,001,000
  • Beta: 0.6
  • Net Margins: -1.64%
  • Return on Equity: 8.01%
  • Return on Assets: 1.97%
  • Debt-to-Equity Ratio: 2.02%
  • Current Ratio: 2.14%
  • Quick Ratio: 1.65%
Additional Links:
Companies Related to Alere:

Analyst Ratings

Consensus Ratings for Alere (NYSE:ALR) (?)
Ratings Breakdown: 2 Hold Ratings, 4 Buy Ratings
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: $49.50 (23.56% upside)

Analysts' Ratings History for Alere (NYSE:ALR)
DateFirmActionRatingPrice TargetDetails
12/8/2016Canaccord GenuitySet Price TargetBuy$52.00View Rating Details
11/4/2016Goldman Sachs Group, Inc. (The)Lower Price TargetNeutral$45.00 -> $42.00View Rating Details
9/1/2016BTIG ResearchReiterated RatingBuy$48.00View Rating Details
8/4/2016Jefferies Group LLCReiterated RatingHoldView Rating Details
7/12/2016Leerink SwannReiterated RatingBuy$56.00View Rating Details
4/29/2016Craig HallumUpgradeHold -> BuyView Rating Details
2/2/2016Raymond James Financial, Inc.DowngradeOutperform -> Market PerformView Rating Details
11/5/2015WedbushLower Price TargetNeutral$43.00 -> $39.00View Rating Details
(Data available from 2/22/2015 forward)


Earnings History for Alere (NYSE:ALR)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/4/2016Q3 16$0.54$0.19$605.50 million$582.00 millionViewN/AView Earnings Details
9/6/2016Q216$0.58($0.46)$611.10 millionViewN/AView Earnings Details
8/17/2016Q116$0.56($0.18)$578.00 millionViewN/AView Earnings Details
8/8/2016Q415$0.58($0.28)$662.04 million$623.00 millionViewN/AView Earnings Details
11/4/2015Q315$0.61$0.54$646.29 million$602.00 millionViewN/AView Earnings Details
8/4/2015Q215$0.54$0.54$625.67 million$629.00 millionViewN/AView Earnings Details
5/5/2015Q115$0.49$0.57$612.93 million$610.40 millionViewN/AView Earnings Details
2/10/2015Q414$0.63$0.60$698.56 million$666.90 millionViewN/AView Earnings Details
10/28/2014Q314$0.52$0.48$743.30 million$736.20 millionViewN/AView Earnings Details
8/4/2014Q214$0.58$0.42$747.55 million$738.30 millionViewN/AView Earnings Details
4/29/2014Q114$0.55$0.55$738.70 million$716.60 millionViewN/AView Earnings Details
2/6/2014Q413$0.62$0.68$770.70 million$772.30 millionViewN/AView Earnings Details
10/29/2013Q313$0.53$0.59$737.66 million$753.90 millionViewN/AView Earnings Details
7/31/2013Q2 2013$0.48$0.64$720.24 million$764.00 millionViewN/AView Earnings Details
5/9/2013Q1 2013$0.51$0.53$727.66 million$739.20 millionViewN/AView Earnings Details
2/15/2013Q4 2012$0.57$0.55$714.75 million$755.80 millionViewN/AView Earnings Details
11/8/2012Q312$0.53$0.43$690.76 million$691.40 millionViewN/AView Earnings Details
8/8/2012$0.53($0.23)ViewN/AView Earnings Details
4/30/2012$0.67$0.77ViewN/AView Earnings Details
2/8/2012$0.71$0.74ViewN/AView Earnings Details
10/26/2011$0.57$0.67ViewN/AView Earnings Details
7/27/2011$0.58$0.46ViewN/AView Earnings Details
4/27/2011$0.61$0.61ViewN/AView Earnings Details
2/17/2011$0.66$0.71ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Alere (NYSE:ALR)
Current Year EPS Consensus Estimate: $1.93 EPS
Next Year EPS Consensus Estimate: $2.28 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161$0.41$0.41$0.41
Q2 20161$0.54$0.54$0.54
Q3 20163$0.45$0.52$0.49
Q4 20163$0.53$0.65$0.57
(Data provided by Zacks Investment Research)


Dividend History for Alere (NYSE:ALR)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Alere (NYSE:ALR)
Insider Ownership Percentage: 3.66%
Institutional Ownership Percentage: 91.82%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/1/2016Melissa GuerdanSVPSell2,500$54.00$135,000.00View SEC Filing  
11/13/2015Robert Bernard HargadonSVPBuy1,000$38.99$38,990.00View SEC Filing  
11/12/2015James F HinrichsCFOBuy10,000$39.97$399,700.00View SEC Filing  
9/3/2015Mark GladwellVPSell2,651$52.27$138,567.77View SEC Filing  
9/3/2015Melissa GuerdanSVPSell5,135$52.00$267,020.00View SEC Filing  
9/1/2015Melissa GuerdanSVPSell5,000$50.48$252,400.00View SEC Filing  
8/31/2015Mark GladwellVPSell27,513$52.23$1,437,003.99View SEC Filing  
8/14/2015Sanjay MalkaniInsiderSell31,460$54.60$1,717,716.00View SEC Filing  
6/8/2015Sanjay MalkaniInsiderSell24,331$50.87$1,237,717.97View SEC Filing  
6/4/2015Sanjay MalkaniInsiderSell15,669$52.18$817,608.42View SEC Filing  
6/1/2015John BridgenSVPSell7,500$51.19$383,925.00View SEC Filing  
4/6/2015Melissa GuerdanSVPSell2,500$50.00$125,000.00View SEC Filing  
3/23/2015Melissa GuerdanSVPSell13,476$48.35$651,564.60View SEC Filing  
3/17/2015John BridgenSVPSell25,000$48.53$1,213,250.00View SEC Filing  
3/16/2015Carla FlakneCAOSell8,500$48.99$416,415.00View SEC Filing  
1/16/2015Carla FlakneCAOSell10,000$42.45$424,500.00View SEC Filing  
12/24/2014Don DudekDirectorBuy40,000$0.01$500.00
12/11/2014John BridgenSVPSell50,000$37.07$1,853,500.00View SEC Filing  
8/15/2014Dave TeitelCFOSell10,000$35.07$350,700.00View SEC Filing  
8/15/2013Dave TeitelCFOSell10,000$31.73$317,300.00View SEC Filing  
8/5/2013Michael Lester CottonInsiderSell12,500$33.82$422,750.00View SEC Filing  
5/31/2013Michael Lester CottonInsiderSell8,750$25.86$226,275.00View SEC Filing  
3/5/2013John QuelchDirectorSell20,220$23.49$474,967.80View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Alere (NYSE:ALR)
News IconFollowing the Numbers on Shares of Alere Inc. (NYSE:ALR) - Searcy News (NYSE:ALR) - February 21 at 3:43 PM logoALR April 21st Options Begin Trading - Nasdaq (NYSE:ALR) - February 21 at 3:43 PM
News IconSell-side is Weighing in on Alere Inc. (NYSE:ALR) Earnings - Aiken Advocate (NYSE:ALR) - February 21 at 7:05 AM logoThe Dividend Growth Portfolio To Grow Old With - Update III: Is It Time To Stock Up On Cash? (NYSE:ALR) - February 20 at 6:55 AM
News IconAlere Inc. (NYSE:ALR) Consensus Price At $52.5 - Transcript Daily (NYSE:ALR) - February 18 at 9:33 AM
News IconTraders Secrets on Alere Inc. (ALR), Zendesk, Inc. (ZEN ... - StockNewsJournal (NYSE:ALR) - February 16 at 3:30 PM
News IconInvestor Circle: Watching the Numbers on Shares of Alere Inc. (NYSE:ALR) - Baldwin Journal (NYSE:ALR) - February 15 at 2:05 AM logoDysfunction, Heartbreak And Love: 11 Most Interesting Corporate Couples (NYSE:ALR) - February 14 at 9:05 PM logoAlere (ALR) Shares Cross Above 200 DMA (NYSE:ALR) - February 14 at 9:05 PM
News IconAlere Inc. (NYSE:ALR) Stock Price Target Given At $52.5 - Transcript Daily (NYSE:ALR) - February 11 at 8:29 PM
News IconA Look at the Technicals on Alere Inc. (NYSE:ALR) - Rives Journal (NYSE:ALR) - February 10 at 3:56 PM logoWall Street's M&A Chatter From January 25 (NYSE:ALR) - February 10 at 3:56 PM
News IconAlere Inc. (NYSE:ALR) EPS Forecast Given As $0.61 - Transcript Daily (NYSE:ALR) - February 9 at 8:31 PM logoCommit To Purchase Alere At $30, Earn 8.3% Annualized Using Options (NYSE:ALR) - February 9 at 1:43 AM
News IconCompany Spotlight on Shares of Alere Inc. (NYSE:ALR) - Baldwin Journal (NYSE:ALR) - February 8 at 3:41 PM logoAlere Inc. (NYSE:ALR) EPS Projection At $0.61 - (NYSE:ALR) - February 4 at 3:32 PM logoAlere : Research Reports Initiation on Medical Laboratories Stocks -- Organovo, DexCom, Quest Diagnostics, and Alere (NYSE:ALR) - February 2 at 3:29 PM
News IconReviewing Indicator Levels for Alere Inc. (ALR) - Springdale Times (NYSE:ALR) - January 31 at 3:39 PM
News IconAnalysts Take: Alere Inc. (NYSE:ALR) Projected Earnings & Price Targets - Aiken Advocate (NYSE:ALR) - January 31 at 1:49 AM
News IconStock in Focus: Alere Inc. (NYSE:ALR) - The Tribune (NYSE:ALR) - January 30 at 3:39 PM
News IconAlere Inc. (NYSE:ALR) Quarterly EPS Projection At $0.47 - Stock Observer (NYSE:ALR) - January 29 at 8:28 PM logoEPS Projection Of Alere Inc. (NYSE:ALR) At $0.61 - (NYSE:ALR) - January 28 at 3:28 PM
News IconReviewing Indicator Levels for Alere Inc. (ALR) - Market Point (NYSE:ALR) - January 27 at 3:36 PM
News IconEarnings in Full Force, Analysts Take Aim at Alere Inc. (NYSE:ALR) - Wall Street Beacon (NYSE:ALR) - January 27 at 3:36 PM
News IconCheyne Capital Management Uk Llp Stake in Alere INC (ALR) Trimmed by $3.25 Million - The Randolph Guide (NYSE:ALR) - January 27 at 3:36 PM logoAlere (ALR) Announces EC Granted Clearance for Abbott's (ABT) Acquisition of Alere (NYSE:ALR) - January 27 at 1:47 AM logoEuropean Commission Clears Abbott Acquisition of Alere (NYSE:ALR) - January 27 at 1:47 AM logo11:02 am Alere confirms its pending acquisition by Abbott Laboratories (ABT (NYSE:ALR) - January 27 at 1:47 AM
News IconGoing The Extra Mile: Stock With Track Record & Upside: Alere Inc. (NYSE:ALR) - Wall Street Beacon (NYSE:ALR) - January 26 at 3:46 PM
News IconVolatility Numbers in View for Alere Inc. (NYSE:ALR) - The Tribune (NYSE:ALR) - January 26 at 3:46 PM
News IconWhat Analysts Report Shows About Alere Inc. (NYSE:ALR ... - Transcript Daily (NYSE:ALR) - January 25 at 8:33 PM logoAnalysts Rating Of Alere Inc. (NYSE:ALR) At 1.8 - (NYSE:ALR) - January 25 at 8:33 PM logoThe Timeline Of A Contentious History: Abbott And Alere (NYSE:ALR) - January 25 at 4:49 PM logoAlere Inc. (NYSE:ALR) Deferred Tax Assets At $15.424 Millions - (NYSE:ALR) - January 25 at 3:33 PM logoAlere (ALR) Announces EC Granted Clearance for Abbott's (ABT) Acquisition of Alere - (NYSE:ALR) - January 25 at 3:33 PM logoEU clears Abbott acquisition of Alere subject to divestments (NYSE:ALR) - January 25 at 11:01 AM logoEuropean regulators OK with Abbott's takeover of Alere if certain assets divested (NYSE:ALR) - January 25 at 10:40 AM
News IconTechnical Investor Update on Shares of Alere Inc. (ALR) - Market Point (NYSE:ALR) - January 24 at 3:49 PM logoAlere, Inc. breached its 50 day moving average in a Bearish Manner : ALR-US : January 24, 2017 (NYSE:ALR) - January 24 at 3:49 PM
News IconStock Update: Estimates & Target in Focus for Alere Inc. (NYSE:ALR) - Aiken Advocate (NYSE:ALR) - January 23 at 8:30 PM
News IconValue Composite Score Update on Alere Inc. (NYSE:ALR) - The Tribune (NYSE:ALR) - January 23 at 3:30 PM
News IconWill The Needle Move For Alere Inc. (NYSE:ALR) Shares This ... - Wall Street Beacon (NYSE:ALR) - January 22 at 3:27 PM
News IconInvestor Guide: Check on Technical Levels for Alere Inc. (ALR) - Rives Journal (NYSE:ALR) - January 22 at 3:27 PM
News IconStock Under Review: Checking in on Levels for Alere Inc. (ALR) - Sherwood Daily (NYSE:ALR) - January 21 at 3:26 PM logoAlere Inc. (NYSE:ALR) EPS Estimate At $0.61 - (NYSE:ALR) - January 21 at 3:26 PM
News IconNoteworthy Friday Option Activity: ALR, RGLD, UNT (NYSE:ALR) - January 20 at 9:03 PM
News IconABR Of Alere Inc. (NYSE:ALR) At 1.8 - Stock Observer (NYSE:ALR) - January 20 at 3:58 PM
News IconSteady As She Goes, Accelerated Growth Puts Stock in Focus: Alere Inc. (NYSE:ALR) - Wall Street Beacon (NYSE:ALR) - January 19 at 3:50 PM
News IconStock On Watch: Institutional Investor Sentiment About Alere Inc (NYSE:ALR) Increased - Fair View Times (NYSE:ALR) - January 19 at 3:50 PM logoQuarterly Deferred Tax Assets Of Alere Inc. (NYSE:ALR) At $15.424 Millions (NYSE:ALR) - January 18 at 8:59 PM


What is Alere's stock symbol?

Alere trades on the New York Stock Exchange (NYSE) under the ticker symbol "ALR."

Where is Alere's stock going? Where will Alere's stock price be in 2017?

6 analysts have issued 12 month price targets for Alere's stock. Their forecasts range from $42.00 to $56.00. On average, they expect Alere's share price to reach $49.50 in the next year.

When will Alere announce their earnings?

Alere is scheduled to release their next quarterly earnings announcement on Friday, November, 4th 2016.

What are analysts saying about Alere stock?

Here are some recent quotes from research analysts about Alere stock:

  • According to Zacks Investment Research, "Alere Inc., formerly known as Inverness Medical Innovations, Inc., provides products and services, which focus on infectious disease, cardiology, oncology, drugs of abuse and women's health. Alere is headquartered in Waltham, Massachusetts. " (1/9/2017)

  • Canaccord Genuity analysts commented, "We offer follow-on color after speaking to Alere in some detail in the wake of the company’s receipt of a subpoena from the US Department of Justice (DoJ) related to sales practices in Africa, Asia and Latin America, as well as items related to the US Foreign Corrupt Practices Act (FCPA). Bottom line, we expect the Alere/Abbott deal to be completed sometime by the end of 2016, though not without drama along the way. We reiterate our HOLD and $56 PT despite what we view as at least modest additional risk to the closing of the deal. We think Alere’s 7.7% decline yesterday did bear some sympathy from Valeant’s sharp 51% decline, though we think the ~12% spread between Alere’s closing price and the deal price roughly calibrates the risk at this time. More detail on emerging market revenue. While a significant ~46% of ALR’s revenue base is derived internationally: 1. Alere believes that a portion of a portion" of its emerging market businesses are more likely to be investigated, not the whole of its businesses in Asia Pacific (13% of total revs) and Africa/Latin America (12% of total revs combined). 2. Alere’s position is that hypothetically, if any of its commercial practices are found to have been inappropriate or illegal, that a % of a % of revenues would need to be re- stated, and in that case, would not constitute a material adverse event. 3." (3/16/2016)

Who owns Alere stock?

Alere's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Iridian Asset Management LLC CT (5.70%), Dimensional Fund Advisors LP (3.17%), CNH Partners LLC (2.34%), Alpine Associates Management Inc. (1.46%), Gabelli Funds LLC (1.38%) and Marshall Wace LLP (0.74%). Company insiders that own Alere stock include Carla Flakne, James F Hinrichs, John Bridgen, Mark Gladwell, Melissa Guerdan, Robert Bernard Hargadon and Sanjay Malkani.

Who sold Alere stock? Who is selling Alere stock?

Alere's stock was sold by a variety of institutional investors in the last quarter, including Alpine Associates Management Inc., Gabelli Funds LLC, Marshall Wace LLP, Gamco Investors INC. ET AL, GABELLI & Co INVESTMENT ADVISERS INC., Iridian Asset Management LLC CT, Dimensional Fund Advisors LP and Two Sigma Investments LP.

Who bought Alere stock? Who is buying Alere stock?

Alere's stock was bought by a variety of institutional investors in the last quarter, including Prudential PLC, Everett Capital Advisors UK LLP, Mcclain Value Management LLC, Renaissance Technologies LLC, Dumac Inc., Stonepine Capital Management LLC, Gardner Lewis Asset Management L P and Folger Hill Asset Management LP. Company insiders that have bought Alere stock in the last two years include James F Hinrichs and Robert Bernard Hargadon.

How do I buy Alere stock?

Shares of Alere can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Alere stock cost?

One share of Alere stock can currently be purchased for approximately $40.06.

Alere (NYSE:ALR) Chart for Wednesday, February, 22, 2017

Institutional Ownership Chart

Institutional Ownership by Quarter for Alere (NYSE:ALR)

Earnings History Chart

Earnings by Quarter for Alere (NYSE:ALR)

Dividend History Chart

Dividend Payments by Quarter for Alere (NYSE:ALR)

Last Updated on 2/22/2017 by Staff